title: Restricted protein phosphatase 2A targeting by Merkel cell polyomavirus small T antigen.
abstract: Merkel cell polyomavirus (MCV) is a newly discovered human cancer virus encoding a small T (sT) oncoprotein. We performed MCV sT FLAG-affinity purification followed by mass spectroscopy (MS) analysis, which identified several protein phosphatases (PP), including PP2A A and C subunits and PP4C, as potential cellular interacting proteins. PP2A targeting is critical for the transforming properties of nonhuman polyomaviruses, such as simian virus 40 (SV40), but is not required for MCV sT-induced rodent cell transformation. We compared similarities and differences in PP2A binding between MCV and SV40 sT. While SV40 sT coimmunopurified with subunits PP2A Aα and PP2A C, MCV sT coimmunopurified with PP2A Aα, PP2A Aβ, and PP2A C. Scanning alanine mutagenesis at 29 sites across the MCV sT protein revealed that PP2A-binding domains lie on the opposite molecular surface from a previously described large T stabilization domain (LSD) loop that binds E3 ligases, such as Fbw7. MCV sT-PP2A interactions can be functionally distinguished by mutagenesis from MCV sT LSD-dependent 4E-BP1 hyperphosphorylation and viral DNA replication enhancement. MCV sT has a restricted range for PP2A B subunit substitution, inhibiting only the assembly of B56α into the phosphatase holoenzyme. In contrast, SV40 sT inhibits the assembly of B55α, B56α and B56ε into PP2A. We conclude that MCV sT is required for Merkel cell carcinoma growth, but its in vitro transforming activity depends on LSD interactions rather than PP2A targeting.
  
  
  OBJECTIVE
  Merkel cell polyomavirus is a newly discovered human cancer virus that promotes cancer, in part, through expression of its small T (sT) oncoprotein. Animal polyomavirus sT oncoproteins have been found to cause experimental tumors by blocking the activities of a group of phosphatases called protein phosphatase 2A (PP2A). Our structural analysis reveals that MCV sT also displaces the B subunit of PP2A to inhibit PP2A activity. MCV sT, however, only displaces a restricted subset of PP2A B subunits, which is insufficient to cause tumor cell formation in vitro. MCV sT instead transforms tumor cells through another region called the large T stabilization domain. The PP2A targeting and transforming activities lie on opposite faces of the MCV sT molecule and can be genetically separated from each other.
authors: Cancer Virology Program, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
authors: Hyun Jin
authors: HJ
authors: Kwun
authors: Cancer Virology Program, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
authors: Masahiro
authors: M
authors: Shuda
authors: Department of Computational Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
authors: Carlos J
authors: CJ
authors: Camacho
authors: Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.
authors: Armin M
authors: AM
authors: Gamper
authors: Cancer Virology Program, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
authors: Mamie
authors: M
authors: Thant
authors: Cancer Virology Program, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
authors: Yuan
authors: Y
authors: Chang
authors: Cancer Virology Program, University of Pittsburgh, Pittsburgh, Pennsylvania, USA yc70@pitt.edu psm9@pitt.edu.
authors: Patrick S
authors: http://orcid.org/0000-0002-8132-858X
authors: PS
authors: Moore
mesh_terms: D000952:Antigens, Polyomavirus Transforming / Q000235:genetics / Q000378:metabolism*; D002471:Cell Transformation, Neoplastic / Q000378:metabolism*; D002846:Chromatography, Affinity; D057809:HEK293 Cells; D006801:Humans; D015151:Immunoblotting; D047468:Immunoprecipitation; D013058:Mass Spectrometry; D059965:Merkel cell polyomavirus / Q000378:metabolism*; D016296:Mutagenesis; D011485:Protein Binding; D054648:Protein Phosphatase 2 / Q000378:metabolism*; D017434:Protein Structure, Tertiary
chemical_list: D000952:Antigens, Polyomavirus Transforming; D054648:Protein Phosphatase 2
references: World J Virol. 2012 Dec 12;1(6):154-61
references: 24175221
references: Mol Cell. 2009 Mar 13;33(5):537-45
references: 19285938
references: J Virol. 2010 Jul;84(14):7064-72
references: 20444890
references: Mol Cell Biol. 2002 Apr;22(7):2111-23
references: 11884599
references: Int J Cancer. 2010 May 1;126(9):2240-6
references: 19551862
references: Trends Mol Med. 2008 Apr;14(4):152-60
references: 18329957
references: J Virol. 2015 Jan;89(1):35-47
references: 25320307
references: Cell. 1987 Jan 30;48(2):321-30
references: 3026642
references: Oncogene. 2005 Nov 21;24(52):7746-55
references: 16299534
references: Nat Struct Mol Biol. 2007 Jun;14(6):527-34
references: 17529992
references: Trends Genet. 1998 Apr;14(4):144-50
references: 9594662
references: Genes Dev. 2013 Dec 1;27(23):2531-6
references: 24298052
references: J Virol. 2009 Dec;83(23):12118-28
references: 19759150
references: Genes Dev. 1993 Apr;7(4):555-69
references: 8384581
references: Viruses. 2013 Dec;5(12):3192-212
references: 24351799
references: J Invest Dermatol. 2009 Jan;129(1):248-50
references: 18633441
references: Oncogene. 2000 Feb 24;19(9):1191-5
references: 10713707
references: EMBO J. 2000 Nov 1;19(21):5672-81
references: 11060018
references: Oncogene. 2001 Apr 5;20(15):1892-9
references: 11313937
references: J Biol Chem. 1996 Sep 6;271(36):22081-9
references: 8703017
references: Science. 2008 Feb 22;319(5866):1096-100
references: 18202256
references: J Invest Dermatol. 2013 Aug;133(8):2059-64
references: 23439392
references: PLoS One. 2011;6(7):e22468
references: 21799863
references: Int J Cancer. 2009 Sep 15;125(6):1243-9
references: 19499546
references: Cancer Res. 2005 Sep 15;65(18):8183-92
references: 16166293
references: Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):388-92
references: 8380637
references: Cell. 2007 Jun 1;129(5):969-82
references: 17540176
references: J Biol Chem. 2007 Sep 14;282(37):26971-80
references: 17635907
references: Nat Rev Cancer. 2010 Dec;10(12):878-89
references: 21102637
references: J Mol Biol. 2004 Feb 27;336(4):971-86
references: 15095873
references: J Clin Invest. 2011 Sep;121(9):3623-34
references: 21841310
references: J Biol Chem. 2010 Jun 11;285(24):18144-54
references: 20378546
references: J Virol. 2013 Mar;87(5):2508-17
references: 23255786
references: Cancer Res. 2010 Dec 15;70(24):10474-84
references: 21159657
references: Gut. 2000 Aug;47(2):268-71
references: 10896920
references: J Virol. 2002 Nov;76(21):10685-91
references: 12368310
references: Oncogene. 2001 Jan 4;20(1):10-5
references: 11244497
references: Biochim Biophys Acta. 2009 Jan;1795(1):1-15
references: 18588945
references: Mol Cell Proteomics. 2005 Nov;4(11):1725-40
references: 16085932
references: Cells. 2012 Jun 25;1(3):204-47
references: 24710474
references: J Natl Cancer Inst. 2009 Nov 4;101(21):1510-22
references: 19776382
references: EMBO J. 2000 Nov 1;19(21):5682-91
references: 11060019
references: Cancer Res. 2008 Jul 1;68(13):5009-13
references: 18593898
references: Science. 1998 Oct 9;282(5387):284-7
references: 9765152
references: Cell Host Microbe. 2013 Aug 14;14(2):125-35
references: 23954152
references: Nat Rev Microbiol. 2008 Apr;6(4):266-75
references: 18311165
references: Mol Biol Cell. 2001 Jan;12(1):185-99
references: 11160832
references: J Virol. 2007 Oct;81(20):11332-40
references: 17686852
references: Mol Cell Biol. 1993 Jan;13(1):367-72
references: 8380224
references: J Biol Chem. 2001 Jan 12;276(2):1570-7
references: 11038366
references: Science. 1992 Aug 28;257(5074):1261-4
references: 1325671
references: Biochim Biophys Acta. 2011 Nov;1812(11):1498-507
references: 21856415
references: J Biol Chem. 1994 Mar 18;269(11):7957-62
references: 7510677
references: J Virol. 2013 Dec;87(24):13853-67
references: 24109239
references: J Biol Chem. 2008 Jan 25;283(4):1882-92
references: 18042541
references: Cell. 2004 Jun 11;117(6):699-711
references: 15186772
references: Front Immunol. 2013 Jan 07;3:401
references: 23316192
references: J Virol. 2005 Jul;79(14):8742-9
references: 15994768
references: Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2979-84
references: 17301223
references: Cell. 1990 Jan 12;60(1):167-76
references: 2153055
references: J Biol Chem. 1995 Sep 8;270(36):21374-81
references: 7673173
references: Science. 1999 Mar 26;283(5410):2089-91
references: 10092233
references: Eur J Neurosci. 2002 Dec;16(11):2039-48
references: 12473071
references: Cancer Cell. 2004 Feb;5(2):127-36
references: 14998489
references: PLoS Biol. 2007 Aug;5(8):e202
references: 17608567
references: J Biol Chem. 2008 Oct 24;283(43):29273-84
references: 18715871
references: J Invest Dermatol. 2015 May;135(5):1415-24
references: 25313532
references: Cell. 2009 Oct 30;139(3):468-84
references: 19879837